» Articles » PMID: 17888148

The HIV RNA Setpoint Theory Revisited

Overview
Journal Retrovirology
Publisher Biomed Central
Specialty Microbiology
Date 2007 Sep 25
PMID 17888148
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The evolution of plasma viral load after HIV infection has been described as reaching a setpoint, only to start rising again shortly before AIDS diagnosis. In contrast, CD4 T-cell count is considered to show a stable decrease. However, characteristics of marker evolution over time depend on the scale that is used to visualize trends. In reconsidering the setpoint theory for HIV RNA, we analyzed the evolution of CD4 T-cell count and HIV-1 RNA level from HIV seroconversion to AIDS diagnosis. Follow-up data were used from two cohort studies among homosexual men (N = 400), restricting to the period before highly active antiretroviral therapy became widely available (1984 until 1996). Individual trajectories of both markers were fitted and averaged, both from seroconversion onwards and in the four years preceding AIDS diagnosis, using a bivariate random effects model. Both markers were evaluated on a scale that is directly related to AIDS risk.

Results: Individuals with faster AIDS progression had higher HIV RNA level six months after seroconversion. For CD4 T-cell count, this ordering was less clearly present. However, HIV RNA level and CD4 T-cell count showed qualitatively similar evolution over time after seroconversion, also when stratified by rate of progression to AIDS. In the four years preceding AIDS diagnosis, a non-significant change in HIV RNA increase was seen, whereas a significant biphasic pattern was present for CD4 T-cell decline.

Conclusion: HIV RNA level has more setpoint behaviour than CD4 T-cell count as far as the level shortly after seroconversion is concerned. However, with respect to the, clinically more relevant, marker evolution over time after seroconversion, a setpoint theory holds as much for CD4 T-cell count as for HIV RNA level.

Citing Articles

Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral load.

Gabrielaite M, Bennedbaek M, Rasmussen M, Kan V, Furrer H, Flisiak R PLoS Comput Biol. 2023; 19(1):e1010756.

PMID: 36595537 PMC: 9838853. DOI: 10.1371/journal.pcbi.1010756.


Secondary metabolites produced by endophytic fungi, , as potential inhibitors of the human immunodeficiency virus.

Nzimande B, Kumalo H, Ndlovu S, Mkhwanazi N Front Genet. 2022; 13:1077159.

PMID: 36583026 PMC: 9794146. DOI: 10.3389/fgene.2022.1077159.


Mitochondrial Dysfunction and Insulin Resistance in Pubertal Youth Living with Perinatally Acquired HIV.

Gojanovich G, Jacobson D, Jao J, Russell J, Van Dyke R, Libutti D AIDS Res Hum Retroviruses. 2020; 36(9):703-711.

PMID: 32586116 PMC: 7482121. DOI: 10.1089/AID.2020.0067.


The -HIV syndemic interaction: why treating infection may be crucial for HIV-1 eradication.

Waters R, Ndengane M, Abrahams M, Diedrich C, Wilkinson R, Coussens A Future Virol. 2020; 15(2):101-125.

PMID: 32273900 PMC: 7132588. DOI: 10.2217/fvl-2019-0069.


Have Cells Harboring the HIV Reservoir Been Immunoedited?.

Huang S, McCann C, Mota T, Wang C, Lipkin S, Jones R Front Immunol. 2019; 10:1842.

PMID: 31447850 PMC: 6691121. DOI: 10.3389/fimmu.2019.01842.


References
1.
Geskus R . On the inclusion of prevalent cases in HIV/AIDS natural history studies through a marker-based estimate of time since seroconversion. Stat Med. 2000; 19(13):1753-69. DOI: 10.1002/1097-0258(20000715)19:13<1753::aid-sim487>3.0.co;2-f. View

2.
de Wolf F, Spijkerman I, Schellekens P, Langendam M, Kuiken C, Bakker M . AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion. AIDS. 1997; 11(15):1799-806. DOI: 10.1097/00002030-199715000-00003. View

3.
Ho D . Viral counts count in HIV infection. Science. 1996; 272(5265):1124-5. DOI: 10.1126/science.272.5265.1124. View

4.
Taylor J, Law N . Does the covariance structure matter in longitudinal modelling for the prediction of future CD4 counts?. Stat Med. 1998; 17(20):2381-94. DOI: 10.1002/(sici)1097-0258(19981030)17:20<2381::aid-sim926>3.0.co;2-s. View

5.
Geskus R, Meyer L, Hubert J, Schuitemaker H, Berkhout B, Rouzioux C . Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development. J Acquir Immune Defic Syndr. 2005; 39(3):321-6. DOI: 10.1097/01.qai.0000142017.25897.06. View